Updated:
COVID-19 HPC Consortium
The COVID-19 HPC Consortium launched in March 2020 as a public-private partnership coordinated by the White House Office of Science and Technology Policy.
COVID-19 HPC Consortium
The COVID-19 HPC Consortium launched in March 2020 as a public-private partnership coordinated by the White House Office of Science and Technology Policy. Founding partners included the National Science Foundation, the Department of Energy, and IBM, with participation from major technology companies and national laboratories. Strategy was purely mission-driven: provide researchers worldwide with access to high-performance computing resources for SARS-CoV-2 related projects. The consortium allocated compute time across its partner facilities for molecular dynamics simulations, viral protein modeling, and epidemiological forecasting. More than 100 research proposals were accepted during the initial six-month period, with partners including Oak Ridge National Laboratory and the Texas Advanced Computing Center. The consortium announced in March 2021 that it had supported over 100 research projects, allocating more than 740 petaflops of computing capacity (per the consortium's public communications, 2021). The partnership operated without any financial investment vehicles or permanent staff beyond the partner organizations' existing teams. The consortium's structural differentiator was its no-cost, open-access model for computing resources during a global pandemic — an unprecedented cross-institutional collaboration between government, academia, and private industry. It disbanded as a formal entity in late 2021 as the acute phase of the pandemic receded, but its model has informed subsequent public-private computing initiatives.
General information
Firm type
other
Year founded
2020
AUM
Undisclosed
Location
Region
North America
Country
United States
City
—
Corporate office
United States
Principals
Thomas Zacharia
Director, Oak Ridge National Laboratory (lead partner representative)
France Córdova
Director, National Science Foundation (lead partner representative)
Sector focus
Frequently asked questions
Who funded the COVID-19 HPC Consortium?
The consortium did not operate with a dedicated budget. Participating organizations contributed in-kind resources: computing time, technical expertise, and network infrastructure. Primary contributors included the National Science Foundation, the Department of Energy, IBM, and major academic computing centers (per the consortium's official communications, 2020).
What types of research received compute time?
Projects included molecular dynamics simulations of viral proteins, drug docking studies for repurposing existing drugs, and epidemiological modeling of transmission patterns. All proposals were reviewed for scientific merit and relevance to COVID-19 (per the consortium's website).
How long did the consortium operate?
The COVID-19 HPC Consortium was active from March 2020 through late 2021. As the pandemic entered an endemic phase and dedicated public health infrastructure emerged, the formal allocation process wound down (per public record).
Was the consortium a family office or investment vehicle?
No. The COVID-19 HPC Consortium was a research coordination initiative, not an investment entity. It had no AUM, no investment professionals, and no financial mandate. This profile documents it as a notable public-private health data consortium.
What happened to the consortium's computing resources after it ended?
The partner institutions retained their HPC capacity for ongoing research. Some projects spun off into independent research programs at national laboratories. No formal successor entity exists (public record).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: